Lipocalin2 Suppresses Metastasis of Colorectal Cancer by Attenuating NF-κB-dependent Activation of Snail and Epithelial Mesenchymal Transition

Overview

Journal Mol Cancer

Publisher Biomed Central

Specialties Molecular Biology
Oncology

Date 2016 Dec 4

PMID 27912767

Citations 44

Authors

Meibao Feng

Jieqiong Feng

Wuzhen Chen

Wubin Wang

Xuesong Wu

Jing Zhang

Fangying Xu

Maode Lai

Affiliations

Soon will be listed here.

Abstract

Background: Lipocalin2 (LCN2) is a secretory protein that is aberrantly expressed in several types of cancer and has been involved in metastatic progression. However, neither mechanisms nor the role that LCN2 plays in the metastasis of colorectal cancer are clear.

Methods: LCN2 expression in colorectal cancer was detected by immunohistochemistry in 400 tissue specimens and Kaplan-Meier survival analysis was performed. In vitro, real-time PCR, western blot, colony formation assay, immunofluorescence assay, wound healing assay, migration and invasion experiment were performed to investigate the effects of LCN2 in epithelial mesenchymal transition (EMT), migration and invasion, respectively. In vivo mouse xenograft and metastasis models were utilized to determine tumorigenicity and metastasis ability, and immunohistochemistry, real-time PCR, western blot were used to evaluate the related protein expression. Luciferase reporter assay was used to explore the role of LCN2 on NF-ĸB promoter.

Results: LCN2 was highly expressed in 66.5% of the specimens, and significantly correlated with positive E-cadherin in the membrane and negative nuclear β-catenin. Higher expression of LCN2 together with negative NF-κB expression was negatively related to nuclear accumulation of snail and predicted favorable prognosis. LCN2 blocked cell proliferation, migration and invasion in vitro and in vivo, and inhibited translocation of NF-κB into nucleus. NF-κB could reverse the effect of LCN2 on EMT and promote snail expression. Rescued snail expression had similar effect without influencing NF-κB activity.

Conclusion: LCN2 may be an important negative regulator in EMT, invasion and metastasis of CRC via acting as upstream of NF-κB/snail signaling pathway. Thereby combinative manipulation of LCN2 and NF-κB/snail pathway may represent a novel and promising therapeutic approach for the patients with CRC.

Citing Articles

The role of the C5a-C5aR pathway in iron metabolism and gastric cancer progression.

Ni Q, Yang H, Rao H, Zhang L, Xiong M, Han X Front Immunol. 2025; 15():1522181.

PMID: 39850877 PMC: 11754390. DOI: 10.3389/fimmu.2024.1522181.

Machine learning-based identification of proteomic markers in colorectal cancer using UK Biobank data.

Radhakrishnan S, Nath D, Russ D, Merodio L, Lad P, Daisi F Front Oncol. 2025; 14():1505675.

PMID: 39839775 PMC: 11746037. DOI: 10.3389/fonc.2024.1505675.

Lipocalin-2 and intestinal diseases.

Zhang Z, Peng J, Ding W World J Gastroenterol. 2024; 30(46):4864-4879.

PMID: 39679305 PMC: 11612708. DOI: 10.3748/wjg.v30.i46.4864.

Single-Cell Transcriptomics Reveals Cellular Heterogeneity and Drivers in Serrated Pathway-Driven Colorectal Cancer Progression.

Wang J, Zhang Y, Chen X, Sheng Q, Yang J, Zhu Y Int J Mol Sci. 2024; 25(20).

PMID: 39456726 PMC: 11507054. DOI: 10.3390/ijms252010944.

Tumor-secreted LCN2 impairs gastric cancer progression via autocrine inhibition of the 24p3R/JNK/c-Jun/SPARC axis.

Huang Z, Li Y, Qian Y, Zhai E, Zhao Z, Zhang T Cell Death Dis. 2024; 15(10):756.

PMID: 39424639 PMC: 11489581. DOI: 10.1038/s41419-024-07153-z.

References

De Craene B, Berx G . Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013; 13(2):97-110. DOI: 10.1038/nrc3447. View

Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T . Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer. 2005; 5(9):744-9. DOI: 10.1038/nrc1694. View

Borkham-Kamphorst E, Van de Leur E, Zimmermann H, Karlmark K, Tihaa L, Haas U . Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis. Biochim Biophys Acta. 2013; 1832(5):660-73. DOI: 10.1016/j.bbadis.2013.01.014. View

Tung M, Hsieh S, Yang S, Cheng C, Tsai R, Wang S . Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells. Prostate. 2013; 73(12):1281-90. DOI: 10.1002/pros.22670. View

Xu M, Feng D, Wu H, Wang H, Chan Y, Kolls J . Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6/STAT3. Hepatology. 2014; 61(2):692-702. PMC: 4303493. DOI: 10.1002/hep.27447. View

Wang H, Wu M, Chan M, Pu Y, Chen C, Lee T . Long-term low-dose exposure of human urothelial cells to sodium arsenite activates lipocalin-2 via promoter hypomethylation. Arch Toxicol. 2014; 88(8):1549-59. DOI: 10.1007/s00204-014-1214-x. View

Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y . Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell. 2009; 15(3):195-206. DOI: 10.1016/j.ccr.2009.01.023. View

Ahmed S, Johnson K, Ahmed O, Iqbal N . Advances in the management of colorectal cancer: from biology to treatment. Int J Colorectal Dis. 2014; 29(9):1031-42. DOI: 10.1007/s00384-014-1928-5. View

Madoz-Gurpide J, Lopez-Serra P, Martinez-Torrecuadrada J, Sanchez L, Lombardia L, Casal J . Proteomics-based validation of genomic data: applications in colorectal cancer diagnosis. Mol Cell Proteomics. 2006; 5(8):1471-83. DOI: 10.1074/mcp.M600048-MCP200. View

10.

Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, Sakamoto K . Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. J Exp Clin Cancer Res. 2013; 32:62. PMC: 3847095. DOI: 10.1186/1756-9966-32-62. View

11.

Mahadevan N, Rodvold J, Almanza G, Perez A, Wheeler M, Zanetti M . ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner. BMC Cancer. 2011; 11:229. PMC: 3146445. DOI: 10.1186/1471-2407-11-229. View

12.

Katoh M, Katoh M . Integrative genomic analyses of ZEB2: Transcriptional regulation of ZEB2 based on SMADs, ETS1, HIF1alpha, POU/OCT, and NF-kappaB. Int J Oncol. 2009; 34(6):1737-42. DOI: 10.3892/ijo_00000304. View

13.

Lee E, Kim H, Lee K, Lee H, Lee J, Kim D . Inhibition of the proliferation and invasion of hepatocellular carcinoma cells by lipocalin 2 through blockade of JNK and PI3K/Akt signaling. Int J Oncol. 2010; 38(2):325-33. DOI: 10.3892/ijo.2010.854. View

14.

Cowland J, Muta T, Borregaard N . IL-1beta-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta. J Immunol. 2006; 176(9):5559-66. DOI: 10.4049/jimmunol.176.9.5559. View

15.

Leung L, Radulovich N, Zhu C, Organ S, Bandarchi B, Pintilie M . Lipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma. PLoS One. 2012; 7(10):e46677. PMC: 3464270. DOI: 10.1371/journal.pone.0046677. View

16.

Herszenyi L, Barabas L, Miheller P, Tulassay Z . Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk. Dig Dis. 2014; 33(1):52-7. DOI: 10.1159/000368447. View

17.

Leng X, Lin H, Ding T, Wang Y, Wu Y, Klumpp S . Lipocalin 2 is required for BCR-ABL-induced tumorigenesis. Oncogene. 2008; 27(47):6110-9. PMC: 2756829. DOI: 10.1038/onc.2008.209. View

18.

Shao L, Huang Q, Luo M, Lai M . Detection of the differentially expressed gene IGF-binding protein-related protein-1 and analysis of its relationship to fasting glucose in Chinese colorectal cancer patients. Endocr Relat Cancer. 2004; 11(1):141-8. DOI: 10.1677/erc.0.0110141. View

19.

Sun Y, Yokoi K, Li H, Gao J, Hu L, Liu B . NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models. Clin Cancer Res. 2011; 17(13):4331-40. PMC: 3575684. DOI: 10.1158/1078-0432.CCR-11-0226. View

20.

Ding G, Fang J, Tong S, Qu L, Jiang H, Ding Q . Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer. Prostate. 2015; 75(9):957-68. DOI: 10.1002/pros.22978. View